Case-Based Roundtables on TargetedOnc.com are collaborative, small-group discussions about case-based clinical profiles and engaging peer-dialogue led by an expert physician. These resources offer practicing oncologists and hematologists insight on relevant data, treatment strategies, and varying professional opinions.
LATEST GENITOURINARY CANCERS CONTENT
Considering the Role of Tivozanib After Prior ICI-Based Therapy in RCC
How Disease Burden Shapes First-Line RCC Treatment Selection
Risk, Histology, and Metastatic Site Guide First-Line RCC Treatment Choices
Navigating the Next Step After Progression in ccRCC
Oncologists Weigh Patient Goals, AEs, and Cost in Treating Low-Volume mHSPC
Treatment Goals Guide First-Line Choices in Metastatic RCC
Experts Debate PD-1 Rechallenge After ICI Progression in RCC
Optimizing Second-Line Therapy in Metastatic ccRCC
CASE-BASED ROUNDTABLES
Advertisement
Advertisement